Cubist Pharma (CBST) Tops Q3 EPS by 54c
Tweet
Share
E-mailGet Alerts CBST Hot Sheet
Price: $101.94 --0%
Financial Fact:
Basic net (loss) income per common share (in shares): 75.83M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Basic net (loss) income per common share (in shares): 75.83M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Cubist Pharma (NASDAQ: CBST) reported Q3 EPS of $0.58, $0.54 better than the analyst estimate of $0.04. Revenue for the quarter came in at $309.2 million versus the consensus estimate of $305.5 million.
For earnings history and earnings-related data on Cubist Pharma (CBST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- South Plains Financial Inc. (SPFI) Tops Q1 EPS by 6c
- Primis Financial (FRST) Misses Q1 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
